novolin 70/30

Generic: human insulin

Labeler: novo nordisk
NDC Directory HUMAN OTC DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name novolin 70/30
Generic Name human insulin
Labeler novo nordisk
Dosage Form INJECTION, SUSPENSION
Routes
SUBCUTANEOUS
Active Ingredients

insulin human 100 [iU]/mL

Manufacturer
Novo Nordisk

Identifiers & Regulatory

Product NDC 0169-3007
Product ID 0169-3007_c7164ea1-aa3e-4359-a3f0-a34c78e78398
Product Type HUMAN OTC DRUG
Marketing Category BLA
Application Number BLA019991
Listing Expiration 2026-12-31
Marketing Start 2018-06-01

Pharmacologic Class

Established (EPC)
insulin [epc]
Chemical Structure
insulin [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01693007
Hyphenated Format 0169-3007

Supplemental Identifiers

RxCUI
213442 311048 847187 2049380
UNII
1Y17CTI5SR
NUI
M0011417 N0000175944

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name novolin 70/30 (source: ndc)
Generic Name human insulin (source: ndc)
Application Number BLA019991 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 [iU]/mL
source: ndc
Packaging
  • 5 SYRINGE, PLASTIC in 1 CARTON (0169-3007-15) / 3 mL in 1 SYRINGE, PLASTIC (0169-3007-01)
  • 5 SYRINGE, PLASTIC in 1 CARTON (0169-3007-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3007-12)
source: ndc

Packages (2)

Ingredients (1)

insulin human (100 [iU]/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "c7164ea1-aa3e-4359-a3f0-a34c78e78398", "openfda": {"nui": ["M0011417", "N0000175944"], "unii": ["1Y17CTI5SR"], "rxcui": ["213442", "311048", "847187", "2049380"], "spl_set_id": ["508a2763-3cb7-4be5-9e53-544e84cd9b1f"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin [EPC]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (0169-3007-15)  / 3 mL in 1 SYRINGE, PLASTIC (0169-3007-01)", "package_ndc": "0169-3007-15", "marketing_start_date": "20180601"}, {"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (0169-3007-25)  / 3 mL in 1 SYRINGE, PLASTIC (0169-3007-12)", "package_ndc": "0169-3007-25", "marketing_start_date": "20180601"}], "brand_name": "Novolin 70/30", "product_id": "0169-3007_c7164ea1-aa3e-4359-a3f0-a34c78e78398", "dosage_form": "INJECTION, SUSPENSION", "pharm_class": ["Insulin [CS]", "Insulin [EPC]"], "product_ndc": "0169-3007", "generic_name": "Human Insulin", "labeler_name": "Novo Nordisk", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Novolin", "brand_name_suffix": "70/30", "active_ingredients": [{"name": "INSULIN HUMAN", "strength": "100 [iU]/mL"}], "application_number": "BLA019991", "marketing_category": "BLA", "marketing_start_date": "20180601", "listing_expiration_date": "20261231"}